General
|
| |
http://www.mims.co.uk |
Ophthalmic Preparations, Preservatives and Potential Sensitisers as Ingredients
Potential sensitising agents in eye drops and ointments.
|
| |
The Ocular Surface Journal
July 2017
Volume 15, Issue 3, p269-650
|
TFOS International Dry Eye WorkShop (DEWS II) |
 |
C Baudouin et al. |
Revisiting the vicious circle of dry eye disease: a focus on the pathophysiology of meibomian gland dysfunction |
 |
The Ocular Surface Journal
April 2007
Volume 5, Number 2 |
International Dry Eye Workshop (DEWS) 2007 |
 |
Pasquale Aragona, Vincenzo Papa, Antonio Micali,
Marcello Santocono, Giovanni Milazzo |
Long term treatment with sodium hyaluronate-containing artificial tears reduces ocular surface damage in patients with dry eye |
 |
H Mochizuki, M Yamada,
S Hato and T Nishida |
Fluorophotometric measurement of the precorneal residence time of topically applied hyaluronic acid |
 |
Brignole F, Pisella PJ, Dupas B, Baeyens V, Baudoin C
Graefes Arch Clin Exp Ophthalmol. 2005 Jun;243(6):531-8. Epub 2004 Dec 17 |
Efficacy and safety of 0.18% sodium hyaluronate in patients with moderate dry eye syndrome and superficial keratitis |
 |
Prabhasawat P, Tesavibul N, Kasetsuwan N.
Br. J. Ophthalmol. 2007;91;47-50 |
Performance profile of sodium hyaluronate in patients with lipid tear deficiency: randomised, double-blind, controlled, exploratory study |
REMOGEN® Omega
|
|
NEW: Stefano Barabino,Jutta Horwath-Winter, Elisabeth M. Messmer, Maurizio Rolando, Pasquale Aragona, Shigeru Kinoshita |
The role of systemic and topical fatty acids for dry eye treatment https://doi.org/10.1016/j.preteyeres.2017.05.003 |
VISMED®
|
| |
NEW: Szegedi S, et al. |
Effect of Single Instillation of Two Hyaluronic Acid-Based Topical Lubricants on Tear Film Thickness in Patients with Dry Eye Syndrome |
| |
Baeyens V, Fiorentini R,
Baudouin C, Dorsey F and The French VISMED® Study Group |
Efficacy and safety of sodium hyaluronate 0.18% (VISMED®) vs sodium chloride 0.9% in patients with bilateral moderate dry eye (Need to register to access full free pdf file) |
| |
Ralph Pinheiro, Claudia Panfil, Norbert Schrage, Ralf Michael Dutescu |
Comparison of the lubricant eyedrops Optive®, Vismed Multi®, and Cationorm® on the corneal healing process in an ex vivo model
|
 |
Roger Vogel, R. Stephens Crockett, Neal Oden, Terry W. Laliberte, and Luis Molina, on behalf of the sodium hyaluronate ophthalmic solution study group |
Demonstration of Efficacy in the Treatment of Dry Eye Disease with 0.18% Sodium Hyaluronate Ophthalmic Solution (Vismed, Rejena) |
 |
C.A. Kirby, and The Vismed Study Group. Invest. Ophthalmol. Vis. Sci. 2009; 50 : E-Abstract 4648-D892. Poster presented at the ARVO, Fort-Lauderdale, 3-7 May 2009 |
Superiority of Vismed® (Sodium Hyaluronate Ophthalmic Solution 0.18%) Compared with its Vehicle in the Treatment of the Signs and Symptoms of Dry Eye Disease |
 |
Baeyens V, Fiorentini R,
Baudouin C, Dorsey F and The French VISMED® Study Group |
Efficacy and safety of sodium hyaluronate 0.18% (VISMED®) vs sodium chloride 0.9% in patients with bilateral moderate dry eye |
 |
Zeher M, Bereczki Á, Sohajda Z, Márta J, Deák G, Ibnou-Zekri N, Baeyens V, poster presented at the 7th International Symposium on Ocular Pharmacology (ISOPT)-Budapest, Hungary, February 28- March 2, 2008 |
A 1-month study of efficacy and safety of 0.18% sodium hyaluronate (Vismed®) vs. 0.3% carbomer and 0.9% saline in patients with bilateral moderate dry eye syndrome |
 |
Johnson ME, Murphy PJ, Boulton M
Graefes Arch Clin Exp Ophthalmol. 2006 Jan;244(1):109-12. Epub 2005 Jun 28. |
Effectiveness of sodium hyaluronate eyedrops in the treatment of dry eye |
 |
Aleo D, Bossy L, poster presented at the 7th International Symposium on Ocular Pharmacology (ISOPT)-Budapest, Hungary, February 28- March 2, 2008 |
Considerations on the risk of precipitation of calcium phosphate salts following the use of VISMED® (0.18% sodium hyaluronate) formulation |
 |
Rapisarda A, Battaglia F, Bossy L, poster presented at the 7th International Symposium on Ocular Pharmacology (ISOPT)-Budapest, Hungary, February 28- March 2, 2008 |
Efficacy and safety of hypotonic 0.18% sodium hyaluronate solution (VISMED®) in patients with moderate dry eye - A study of the osmolarity of the tear film |
 |
Michael E. Johnson
Paul J. Murphy
Mike Boulton |
Carbomer and Sodium Hyaluronate Eyedrops for Moderate Dry Eye Treatment |
VISMED® GEL
|
 |
TRB Chemedica |
VISMED® GEL (Non-Preserved Sodium Hyaluronate eye drops) for the Treatment of Symptoms of Ocular Dryness and Discomfort in Patients with Sjögren's Syndrome |
 |
Clive Peckar |
The Use of Sodium Hyaluronate Gel 0.3% in the Management of Post-Keratoplasty Patients, Chronic Refractory Dry Eye Patients and other Surface Problems |
 |
Clive Peckar
Article in Eurotimes. |
Sodium Hyaluronate Based Products. Management of post-LASIK dry eye and other dry eye problems.
|
 |
Clive Peckar et al
Eurotimes Roundtable
|
Current Trends in the management of dry eye |
LASERVIS
|
| |
Dougherty P.J., Wellish K.L., Maloney R.K. (1994) |
Excimer Laser Ablation Rate and Corneal Hydration. Am. J of Ophthalm. 118, 169-176 |
| |
Arshinoff SA, Khoury E.
J Cataract Refract Surg 1997; 23:1221-5. |
HsS versus a balanced salt solution as a corneal wetting agent during routine cataract extraction and lens implantation |
| |
Alio J.L., Belda J.I., Shalaby A.:
2001;108:1246-1260 American Academy of Ophthalmology |
Correction of Irregular Astigmatism with Excimer Laser Assisted by Sodium Hyaluronate |
| |
Vinciguerra P, Camesasca FI.
J Refract Surg 2002; 18(3 Suppl):S371-3. |
Butterfly laser epithelial keratomileusis for myopia |
| |
Lombardo M, Serrao S.(2004):
Excimer Lasers. Journal of Refractive Surgery Vol 20 September/October 2004 |
Smoothing of the ablated porcine anterior corneal surface using Technolas Keratocor 217C and Nidek EC-5000 |
| |
Vinciguerra P., Camesasca FI, Torres IM
Journal of Refractive Surgery Volume 20 September/October (Suppl) 2004 |
One-year results of custom laser epithalial keratomileusis with the Nidek system |
| |
J Cataract Refract Surg 2005;31:39-47 ASCRS & ESCRS
Vinciguerra P., Camesasca F.I., Torres Munoz M.I. (2005): |
Transition zone design and smoothing in custom laser-assisted subepithelial keratectomy |
| |
Vinciguerra P, Munoz MI, Camesasca FI, Grizzi F, Roberts C.
J Cataract Refract Surg. 2005 Jan;31(1):82-7. |
Long-term follow-up of ultrathin corneas after surface retreatment with phototherapeutickeratectomy. |
| |
Lombardo M, De Santo MP, Barberi R, Serrao S.
J Refract Surg. 2005 Sep-Oct;21(5):469-75 |
Roughness of excimer laser ablated corneas with and without smoothing measured with atomic force microscopy |
VISIOL ®
|
| |
Belda JI, Artola A, Garcia-Manzanares MD, Ferrer C, Haroun HE, Hassanein A, Baeyens V, Munoz G, Aliò JL
J Cataract Refract Surg 2005; 31:1213-1218 © 2005 ASCRS and ESCRS |
Hyaluronic acid combined with mannitol to improve protection against free-radical endothelial damage: Experimental Model |
| |
Miranda M, Bosch-Morell F, Belda JI, García-Manzanares MD, Barcia J, Alió JL, Romero FJ
Ophthalmic Res. 2007;39(5):260-4. Epub 2007 Sep 12. |
Protective Effect of Viscoelastics against Retina Lipid Peroxidation |
 |
Peckar C, study results presented at the 24th congress of the Asia-Pacific Academy of Ophthalmology (APAO)-Bali, Indonesia, May 17th, 2009 |
New OVDs: Does 2% Sodium Hyaluronate (VISIOL®) have significant advantages over 1% Sodium Hyaluronate to justify its use in Routine Cataract Phacoemulsification? |